Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Powell

Showing results (31-40 of 138) with videos related to

Pageof 14
Sort By:
Blood|September 4, 2004
Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapyDaniel J Powell, Mark E Dudley, Paul F Robbins, et al.
Frontiers in Immunology|July 7, 2020
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor EscapeAlba Rodriguez-Garcia, Asis Palazon, Estela Noguera-Ortega, et al.
Innate Immunity|June 27, 2012
Dendritic cells and their role in tumor immunosurveillanceMarius Strioga, Virgil Schijns, Daniel J Powell, et al.
Journal of the American Chemical Society|November 26, 2009
Visible light-driven H(2) production by hydrogenases attached to dye-sensitized TiO(2) nanoparticlesErwin Reisner, Daniel J Powell, Christine Cavazza, et al.
Frontiers in Immunology|May 29, 2026
Generation of functional canine TIL products for solid tumorsKay M Foos, Veethika Pandey, Michael W Jennings, et al.
Oncotarget|June 24, 2015
A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicityDe-Gang Song, Qunrui Ye, Mathilde Poussin, et al.
Human Gene Therapy|January 10, 2013
Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibitionDe-Gang Song, Qunrui Ye, Stephen Santoro, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 26, 2007
Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapyDaniel J Powell, Christiaan R de Vries, Tamika Allen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletionDaniel J Powell, Mark E Dudley, Katherine A Hogan, et al.
Cytotherapy|November 12, 2009
Efficient clinical-scale enrichment of lymphocytes for use in adoptive immunotherapy using a modified counterflow centrifugal elutriation programDaniel J Powell, Andrea L Brennan, Zhaohui Zheng, et al.
Pageof 14

Showing results (31-40 of 138) with videos related to

Sort By:
Pageof 14
Blood|September 4, 2004
Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapyDaniel J Powell, Mark E Dudley, Paul F Robbins, et al.
Frontiers in Immunology|July 7, 2020
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor EscapeAlba Rodriguez-Garcia, Asis Palazon, Estela Noguera-Ortega, et al.
Innate Immunity|June 27, 2012
Dendritic cells and their role in tumor immunosurveillanceMarius Strioga, Virgil Schijns, Daniel J Powell, et al.
Journal of the American Chemical Society|November 26, 2009
Visible light-driven H(2) production by hydrogenases attached to dye-sensitized TiO(2) nanoparticlesErwin Reisner, Daniel J Powell, Christine Cavazza, et al.
Frontiers in Immunology|May 29, 2026
Generation of functional canine TIL products for solid tumorsKay M Foos, Veethika Pandey, Michael W Jennings, et al.
Oncotarget|June 24, 2015
A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicityDe-Gang Song, Qunrui Ye, Mathilde Poussin, et al.
Human Gene Therapy|January 10, 2013
Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibitionDe-Gang Song, Qunrui Ye, Stephen Santoro, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 26, 2007
Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapyDaniel J Powell, Christiaan R de Vries, Tamika Allen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletionDaniel J Powell, Mark E Dudley, Katherine A Hogan, et al.
Cytotherapy|November 12, 2009
Efficient clinical-scale enrichment of lymphocytes for use in adoptive immunotherapy using a modified counterflow centrifugal elutriation programDaniel J Powell, Andrea L Brennan, Zhaohui Zheng, et al.
Pageof 14